InVivo: Why InVivo Therapeutics Shares Are Plunging Today
InVivo Therapeutics Holdings Corp (NASDAQ: NVIV) announced topline results from its INSPIRE 2.0 study of Neuro-Spinal Scaffold, a bioresorbable scaffold-based device for acute spinal cord injuries (SCI). The study did not meet ...Full story available on Benzinga.com
Read full article »
InVivo is a Massachusetts-based biotechnology company that develops neurological products for the treatment of spinal cord injuries.
Read more